A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Complera is three drugs in one: two nucleoside analog HIV-1 reverse transcriptase inhibitors, emtricitabine and tenofovir disoproxil fumarate, and one non-nucleoside reverse transcriptase inhibitor, rilpivirine, for the treatment of HIV-1 infection in patients who weigh 35 kg or more.
Complera may not be right for everyone, so talk to your doctor about which treatment option is best for you.
Complera is available in an oral tablet containing 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir disoproxil fumarate.
Carefully read and follow the instructions that come with your prescription. Take Complera as your doctor has prescribed. Any questions or concerns should be addressed with your doctor or pharmacist.
The recommended dose in adult and pediatric patients who weigh 35 kg or more is one tablet by mouth once daily. Take with food.
Two nucleoside analog HIV-1 reverse transcriptase inhibitors, emtricitabine and tenofovir disoproxil fumarate, and one non-nucleoside reverse transcriptase inhibitor, rilpivirine, are contained in each Complera tablet.
Complera should not be given with medications that can decrease its response to HIV-1 or cause the virus to be resistant to Complera. These medications include carbamazepine, phenobarbital, phenytoin, rifampin, rifapentine, dexamethasone, St. John's wort, dexlansoprazole, esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole. Ask your doctor if you are unsure whether or not you take any of these medications.
Complera contains a FDA Boxed Warning regarding severe worsening of hepatitis B virus (HBV) in patients with HIV-1 and HBV who stopped taking medications containing emtricitabine and/or tenofovir disoproxil fumarate.
Complera side effects include depression, headache, trouble sleeping, abnormal dreams, dizziness, nausea, and rash. However, these are not all the side effects that can occur.
Call your doctor immediately if you have side effects that are concerning or won't go away.